ODM-208
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ODM-208, covering 2025-07-22 to 2025-07-22. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer [Phase 1, Phase 2]